@article{17a94f93136e4408a91ffe0b47076871,
title = "Challenges of microRNA-based biomarkers in clinical application for cardiovascular diseases",
keywords = "Artificial Intelligence, Biomarkers/blood, Cardiovascular Diseases/diagnosis, Extracellular Vesicles/metabolism, Humans, MicroRNAs/blood",
author = "{de Gonzalo-Calvo}, David and Jennifer P{\'e}rez-Boza and Joao Curado and Yvan Devaux and {EU-CardioRNA COST Action CA17129}",
note = "This article is based upon work from EU-CardioRNA COST Action CA17129 (www.cardiodrna.eu) supported by COST (European Cooperation in Science and Technology). DdGC has received financial support from Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041), cofunded by the European Social Fund (ESF)/ “Investing in your future.” This work is supported by Instituto de Salud Carlos III (PI20/00577), cofunded by European Regional Development Fund (ERDF)/“A way to make Europe”. CIBERES is an initiative of the Instituto de Salud Carlos III. YD is funded by the EU Horizon 2020 project COVIRNA (Grant Agreement # 101016072), the National Research Fund (Grants #C14/BM/8225223, C17/BM/11613033, and COVID-19/2020-1/14719577/miRCOVID), the Ministry of Higher Education and Research, and the Heart Foundation-Daniel Wagner of Luxembourg.",
year = "2022",
month = feb,
doi = "10.1002/ctm2.585",
language = "English",
volume = "12",
pages = "e585",
journal = "Clinical and Translational Medicine",
issn = "2001-1326",
publisher = "John Wiley & Sons Inc.",
number = "2",
}